Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-439-8 | CAS number: 106-89-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- not specified
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Not GLP, study was conducted in accordance with Guidelines and sufficient data is available for the interpretation of results.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 980
- Report date:
- 1980
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- EPA OPP 81-1 (Acute Oral Toxicity)
- Deviations:
- no
- Remarks:
- Not specified in report
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- 1-chloro-2,3-epoxypropane
- EC Number:
- 203-439-8
- EC Name:
- 1-chloro-2,3-epoxypropane
- Cas Number:
- 106-89-8
- Molecular formula:
- C3H5ClO
- IUPAC Name:
- 2-(chloromethyl)oxirane
- Details on test material:
- 99.8% epichlorohydrin
0.11% 2,3-dichloropropene
0.01% beta-chloroallyl alcohol
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: Fischer 344 and Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Source: Fischer 344 rats: Charles River Breeding Laboratories, Portage, MI; Sprague-Dawley rats: Spartan Research Animals, Inc., Haslett, MI
Age: 7-8 weeks
Mean Weight at Study Initiation: male Fischer 344 rats: 103-185 g female Fischer 344 rats: 80-132 g; male Sprague-Dawley rats: 262-325 g; female Sprague-Dawley rats: 192-208 g
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- Doses per time period: Single-dose oral gavage
Maximum volume administered: Fischer 344 rats: 2.8 ml; Sprague-Dawley rats: 4.7 ml
Post-Dose Observation Period: 2 weeks - Doses:
- 25, 50, 100, 200, 210, 225, 252, 398, 795 mg/kg for male and female Fischer 344 rats
24, 50, 100, 200, 398 and 795 mg/kg for male and female Sprague-Dawley rats. - No. of animals per sex per dose:
- 5/sex/dose
- Control animals:
- no
- Details on study design:
- Examinations: Clinical observations, gross pathological examination
- Statistics:
- Statistics: The acute oral median lethal dose and approximate slope of the dose-response curve for both strains were calculated by the moving average method of Thompson and Weil (Biometrics 8: 51-54, 1952).
Results and discussion
- Preliminary study:
- not applicable
Effect levelsopen allclose all
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 282 mg/kg bw
- 95% CL:
- 117 - 448
- Remarks on result:
- other: Sprague-Dawley rat calculated using moving average method
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 175 mg/kg bw
- 95% CL:
- 116 - 306
- Remarks on result:
- other: Sprague-Dawley rat calculated using moving average method
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- ca. 218 mg/kg bw
- Remarks on result:
- other: Fischer 344 rat calculated using moving average method
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 210 mg/kg bw
- 95% CL:
- 203 - 216
- Remarks on result:
- other: Fischer 344 rat calculated using moving average method
- Mortality:
- MORTALITY:
# Dead/# Treated
Dose Male Female Male Female
(mg/kg) S-D S-D CDF CDF
25 0/5 0/5 0/5 0/5
50 0/5 0/5 0/5 0/5
100 0/5 0/5 0/5 0/5
200 1/5 2/5 0/5 0/5
210 --- --- 0/5 3/5
225 --- --- 5/5 5/5
252 --- --- 5/5 5/5
398 4/5 5/5 5/5 5/5
795 5/5 5/5 5/5 5/5
---: not tested
Time to death not available. - Clinical signs:
- other: CLINICAL SIGNS: # Affected/# Treated Dose Sign Male Female Male Female (mg/kg) S-D S-D CDF CDF 25 0/5 0/5 0/5 0/5 50 0/5 0/5 0/5 0/5 100 0/5
- Gross pathology:
- GROSS PATHOLOGY:
Roughening and thickening of the squamous epithelium of the non-glandular stomach was observed in rats given 100-210 mg/kg with Sprague-Dawley rats exhibiting an increased incidence compared to Fischer 344 rats. Other findings were non-specific and not considered treatment-related. - Other findings:
- POTENTIAL TARGET ORGANS: None identified.
SEX-SPECIFIC DIFFERENCES: No significant differences observed.
Any other information on results incl. tables
The LD50 results were very similar between both strains and sexes with individual values ranging from 175 -282 mg/kg..
Applicant's summary and conclusion
- Interpretation of results:
- Category 3 based on GHS criteria
- Conclusions:
- The LD50 was calculated in male and female Sprague-Dawley and Fischer 344 rats. The LD50 ranged from 175-282 mg/kg.
- Executive summary:
The LD50 was calculated in male and female Sprague-Dawley and Fischer 344 rats for a number of compounds. The LD50 for epichlorohydrin ranged from 175-282 mg/kg.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.